[go: up one dir, main page]

MX2017002362A - Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal. - Google Patents

Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal.

Info

Publication number
MX2017002362A
MX2017002362A MX2017002362A MX2017002362A MX2017002362A MX 2017002362 A MX2017002362 A MX 2017002362A MX 2017002362 A MX2017002362 A MX 2017002362A MX 2017002362 A MX2017002362 A MX 2017002362A MX 2017002362 A MX2017002362 A MX 2017002362A
Authority
MX
Mexico
Prior art keywords
kit
radiolabelling
metal inhibitor
focused
agent
Prior art date
Application number
MX2017002362A
Other languages
English (en)
Other versions
MX379367B (es
Inventor
Wouters Ludovic
KAISIN Geoffroy
LUXEN André
LÉONARD Marc
Voccia Samuel
Original Assignee
Anmi S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anmi S A filed Critical Anmi S A
Publication of MX2017002362A publication Critical patent/MX2017002362A/es
Publication of MX379367B publication Critical patent/MX379367B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Radiation-Therapy Devices (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se relaciona con un kit para el marcaje radiactivo de un agente enfocado con galio-68. La presente invención también se refiere al uso de tal kit para el marcaje radiactivo de un agente enfocado, un método para el marcaje radiactivo de un agente enfocado con galio-68 usando tal kit, tal kit y un método de preparación.
MX2017002362A 2014-08-29 2015-07-28 Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal. MX379367B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE2014/0653A BE1021191B1 (fr) 2014-08-29 2014-08-29 Kit pour radiomarquage.
PCT/EP2015/067211 WO2016030103A1 (en) 2014-08-29 2015-07-28 Kit for radiolabelling with 68ga comprising a metal inhibitor

Publications (2)

Publication Number Publication Date
MX2017002362A true MX2017002362A (es) 2017-09-15
MX379367B MX379367B (es) 2025-03-11

Family

ID=52396314

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017002362A MX379367B (es) 2014-08-29 2015-07-28 Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal.
MX2017002361A MX388098B (es) 2014-08-29 2015-07-28 Mono-, di-, o polisacarido usado como inhibidor de metal en la preparacion del agente enfocado funcionalizado con quelato galio 68 (68ga).

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017002361A MX388098B (es) 2014-08-29 2015-07-28 Mono-, di-, o polisacarido usado como inhibidor de metal en la preparacion del agente enfocado funcionalizado con quelato galio 68 (68ga).

Country Status (20)

Country Link
US (6) US11045563B2 (es)
EP (4) EP3185912B1 (es)
JP (2) JP6552622B2 (es)
CN (2) CN106659806B (es)
AU (7) AU2015309187B2 (es)
BE (1) BE1021191B1 (es)
BR (3) BR112017003710B1 (es)
CA (3) CA2958475C (es)
DK (1) DK3185911T3 (es)
ES (2) ES2855991T3 (es)
FR (1) FR25C1028I1 (es)
HU (1) HUE053971T2 (es)
IL (2) IL250735B (es)
MX (2) MX379367B (es)
NZ (1) NZ729293A (es)
PL (1) PL3185911T3 (es)
PT (1) PT3185911T (es)
RU (2) RU2725627C2 (es)
WO (2) WO2016030103A1 (es)
ZA (1) ZA201702152B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1021191B1 (fr) * 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
GB201504064D0 (en) * 2015-03-10 2015-04-22 Accretion Biotechnology Ltd Method and kits for preparing radionuclide complexes
CN106377527B (zh) * 2016-09-05 2019-02-26 郑州大学 开链吡啶羧酸衍生物H2dedpa在抗菌领域的应用
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
KR20200004861A (ko) 2017-05-05 2020-01-14 퓨전 파마슈티칼즈 인크. Igf-1r 모노클로날 항체 및 그의 용도
EA201992595A1 (ru) 2017-05-05 2020-04-21 Фьюжн Фармасьютикалс Инк. Усиление фармакокинетики бифункциональных хелатов и их применения
JP7338128B2 (ja) * 2017-12-08 2023-09-05 イー、シー、エス、ビオトラッカー、エス、エー、アール、エル 癌診断における放射性標識プロガストリン
US20210276971A1 (en) * 2018-06-20 2021-09-09 The Research Foundation For The State University Of New York Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same
CN110787186B (zh) * 2019-10-22 2020-11-17 华中科技大学 一种Ga3+/PDA靶向协同抗菌纳米材料、其制备和应用
IT202000032603A1 (it) 2020-12-29 2022-06-29 Univ Degli Studi Di Bari Aldo Moro Kit freddi a base di ligandi del psma per l’allestimento di radiofarmaci.
US20240238460A1 (en) 2021-05-31 2024-07-18 Telix Pharmaceuticals (Innovations) Pty Ltd Improved prostate-specific membrane antigen targeting radiopharmaceuticals and uses thereof
MX2024000041A (es) 2021-06-29 2024-04-26 Life Molecular Imaging Ltd Un kit novedoso para la preparación radiofarmacéutica de un conjugado de direccionamiento funcionalizado con quelato, marcado con radiometal.
WO2025242848A1 (en) * 2024-05-23 2025-11-27 Telix Innovations S.A. Radiolabelling kit and method for radiolabelling with 68ga or 67ga

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7902342A (nl) 1979-03-26 1980-09-30 Byk Mallinckrodt Cil Bv Isotopengenerator.
WO2003048207A2 (en) 2001-11-28 2003-06-12 Immunomedics, Inc. Anti-dota antibody
US7011816B2 (en) * 2001-12-26 2006-03-14 Immunomedics, Inc. Labeling targeting agents with gallium-68 and gallium-67
WO2003074005A2 (en) 2002-03-01 2003-09-12 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
GB0308408D0 (en) 2003-04-11 2003-05-21 Amersham Plc Microwave activation
CA2526556C (en) 2003-07-24 2012-09-25 Bracco Imaging S.P.A. Stable radiopharmaceutical compositions and methods for their preparation
EP1846042A2 (en) * 2005-01-05 2007-10-24 Board of Regents, The University of Texas System Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
US8545809B2 (en) * 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
US9408928B2 (en) 2007-03-27 2016-08-09 Radiomedix, Inc. Compositions for targeted imaging and therapy
FR2942227B1 (fr) * 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
WO2010119036A1 (en) * 2009-04-14 2010-10-21 Humagene Inc. Novel post-translational fibrinogen variants
WO2010141833A2 (en) 2009-06-05 2010-12-09 The General Hospital Corporation Vital fluorochrome conjugates and methods of use
US8951064B2 (en) 2010-12-14 2015-02-10 Ideal Industries, Inc. Terminal structures for wiring devices
ITFI20110180A1 (it) * 2011-08-12 2013-02-13 Advanced Accelerator Applic S A Processo per la preparazione di complessi di 68ga.
US9161998B2 (en) * 2012-05-18 2015-10-20 Zentralklinik Bad Berka Gmbh Method and kit for preparing a radiopharmaceutical
EP2912459A2 (en) 2012-10-25 2015-09-02 Life Technologies Corporation Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins
BE1021191B1 (fr) * 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
CN104830316B (zh) * 2015-05-11 2017-02-01 厦门大学 一种用于核素标记的靶向探针及其制备方法和应用
ITUA20163207A1 (it) 2016-05-06 2017-11-06 Azienda Ospedaliera Di Reggio Emilia Arcispedale Santa Maria Nuova Preparazione in kit di radiofarmaci marcati con gallio-68

Also Published As

Publication number Publication date
WO2016030103A1 (en) 2016-03-03
BR112017003578A2 (pt) 2017-12-05
RU2724894C2 (ru) 2020-06-26
US20210268131A1 (en) 2021-09-02
AU2015309188B2 (en) 2020-05-21
WO2016030104A1 (en) 2016-03-03
US20220296735A1 (en) 2022-09-22
IL250736A0 (en) 2017-04-30
US20210275697A1 (en) 2021-09-09
RU2725627C2 (ru) 2020-07-03
PT3185911T (pt) 2021-03-22
BR112017003710B1 (pt) 2021-12-14
NZ729291A (en) 2021-03-26
HUE053971T2 (hu) 2021-07-28
BR122021017474B1 (pt) 2023-10-10
JP6543343B2 (ja) 2019-07-10
US11040120B2 (en) 2021-06-22
ES2856030T3 (es) 2021-09-27
MX379367B (es) 2025-03-11
CA2958475C (en) 2022-07-12
AU2022202346A1 (en) 2022-04-28
CN106659806A (zh) 2017-05-10
ES2855991T3 (es) 2021-09-27
AU2015309188A1 (en) 2017-03-09
EP3862025A1 (en) 2021-08-11
CN106659806B (zh) 2021-01-26
AU2020220193A1 (en) 2020-09-10
US11045563B2 (en) 2021-06-29
AU2022202439B2 (en) 2023-12-14
IL250735A0 (en) 2017-04-30
BE1021191B1 (fr) 2015-10-27
CA2958475A1 (en) 2016-03-03
EP3185911B1 (en) 2020-12-30
JP2017526745A (ja) 2017-09-14
CN106794265B (zh) 2021-01-26
AU2022202439A1 (en) 2022-05-05
MX2017002361A (es) 2017-09-15
IL250735B (en) 2021-04-29
CA3167294C (en) 2024-05-28
NZ729293A (en) 2022-04-29
JP6552622B2 (ja) 2019-07-31
US20180230068A1 (en) 2018-08-16
EP3862026A1 (en) 2021-08-11
CA3167294A1 (en) 2016-03-03
US20180230069A1 (en) 2018-08-16
RU2017109582A3 (es) 2018-12-20
EP3185912B1 (en) 2020-12-30
CA2958471E (en) 2016-03-03
AU2020220194A1 (en) 2020-09-10
BR112017003710A2 (pt) 2017-12-05
CN106794265A (zh) 2017-05-31
US12329829B2 (en) 2025-06-17
BR112017003578B1 (pt) 2023-12-26
RU2017109583A3 (es) 2018-12-26
US20220273827A1 (en) 2022-09-01
JP2017530188A (ja) 2017-10-12
RU2017109583A (ru) 2018-10-01
EP3185911A1 (en) 2017-07-05
IL250736B (en) 2021-04-29
AU2015309187A1 (en) 2017-03-09
MX388098B (es) 2025-03-19
PL3185911T3 (pl) 2021-08-23
EP3185912A1 (en) 2017-07-05
CA2958471A1 (en) 2016-03-03
FR25C1028I1 (fr) 2025-09-19
ZA201702152B (en) 2021-06-30
AU2024205118A1 (en) 2024-08-15
DK3185911T3 (da) 2021-03-15
RU2017109582A (ru) 2018-10-01
CA2958471C (en) 2022-05-31
AU2015309187B2 (en) 2020-05-21

Similar Documents

Publication Publication Date Title
MX2017002362A (es) Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal.
CL2016002772A1 (es) Composiciones de insulina de rápida acción
PT3506886T (pt) Formulações de anticorpos inibidores de masp-2 altamente concentradas e de baixa viscosidade, kits e métodos
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
PH12017500019A1 (en) Novel ultra-high performance concrete
PL3634965T3 (pl) Radiofarmaceutyki, środki do radioobrazowania i ich zastosowania
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
ES2670983T3 (es) Métodos y composiciones relacionados con CRISPR con ARNg rectores
SG10201907142VA (en) Etching composition
PL3419683T3 (pl) Preparaty i zestawy generujące tlenek azotu
GB201617572D0 (en) Use, method, kit, composition and antibodies
CL2016001701A1 (es) Material de enlucido de yeso que contiene un complejo metálico de edta
CL2016002754A1 (es) Dispositivo de tratamiento y procedimiento de tratamiento para el decapado y fosfatado de piezas de metal
BR112018006446A2 (pt) composições lubrificantes e métodos para uso das mesmas
PH12017501022B1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
MX2016007592A (es) Composicion que comprende agente beneficioso y solvente aprotico.
DOP2017000264A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio
BR112018071586A2 (pt) uso de beta-agonistas da tireoide
PT3265579T (pt) Processo não radioativo de determinação da ação citolítica de um agente face a células-alvo, sua utilização e kit associado
MX2018012904A (es) Uso de beta-agonistas del receptor de la hormona tiroidea.
BR112017014842A2 (pt) composição de agente de formação de imagem, kit de agente de formação de imagem, e, método para preparação de uma composição de agente de formação de imagem
MX2017004909A (es) Composiciones de triptamina y metodos de uso.
EP3722021A4 (en) PARTLY DISPERSED ALLOY STEEL POWDER
PL3448555T3 (pl) Stała kompozycja oczyszczająca, sposób jej otrzymywania i jej zastosowania
CL2016001398A1 (es) Silicato de zirconio para el tratamiento de hipercalemia sin co-administración de litio